🚀 VC round data is live in beta, check it out!
Neola Medical Valuation Multiples
Discover revenue and EBITDA valuation multiples for Neola Medical and similar public comparables like Qlife Holding, ScandiDos, Spineway, Bio-Gate and more.
Neola Medical Overview
About Neola Medical
Neola Medical AB is revolutionizing neonatal intensive care with NEOLA, a medical device that can offer continuous lung monitoring and real-time alerts of life-threatening complications using a technology that measures lung volume changes and oxygen gas concentration. NEOLA has the potential to provide care, fewer days in intensive care, and healthier lives for preterm born infants. The company is building on a historic Swedish legacy of medical technology innovation and invaluable contributions to health care.
Founded
2016
HQ
Employees
7
Website
Sectors
Financials (LTM)
EV
$4M
Neola Medical Financials
Neola Medical reported last 12-month revenue of $953K and negative EBITDA of ($1M).
In the same LTM period, Neola Medical generated $953K in gross profit, ($1M) in EBITDA losses, and had net loss of ($1M).
Revenue (LTM)
Neola Medical P&L
In the most recent fiscal year, Neola Medical reported revenue of $933K and EBITDA of ($1M).
Neola Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $953K | XXX | $933K | XXX | XXX | XXX |
| Gross Profit | $953K | XXX | $874K | XXX | XXX | XXX |
| Gross Margin | 100% | XXX | 94% | XXX | XXX | XXX |
| EBITDA | ($1M) | XXX | ($1M) | XXX | XXX | XXX |
| EBITDA Margin | (115%) | XXX | (114%) | XXX | XXX | XXX |
| EBIT Margin | (121%) | XXX | (117%) | XXX | XXX | XXX |
| Net Profit | ($1M) | XXX | ($1M) | XXX | XXX | XXX |
| Net Margin | (120%) | XXX | (116%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Neola Medical Stock Performance
Neola Medical has current market cap of $6M, and enterprise value of $4M.
Market Cap Evolution
Neola Medical's stock price is $0.08.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $4M | $6M | 0.3% | XXX | XXX | XXX | $-0.01 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialNeola Medical Valuation Multiples
Neola Medical trades at 4.6x EV/Revenue multiple, and (4.0x) EV/EBITDA.
EV / Revenue (LTM)
Neola Medical Financial Valuation Multiples
As of April 20, 2026, Neola Medical has market cap of $6M and EV of $4M.
Equity research analysts estimate Neola Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Neola Medical has a P/E ratio of (5.4x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $6M | XXX | $6M | XXX | XXX | XXX |
| EV (current) | $4M | XXX | $4M | XXX | XXX | XXX |
| EV/Revenue | 4.6x | XXX | 4.7x | XXX | XXX | XXX |
| EV/EBITDA | (4.0x) | XXX | (4.2x) | XXX | XXX | XXX |
| EV/EBIT | (3.8x) | XXX | (4.0x) | XXX | XXX | XXX |
| EV/Gross Profit | 4.6x | XXX | 5.0x | XXX | XXX | XXX |
| P/E | (5.4x) | XXX | (5.7x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (3.4x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Neola Medical Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Neola Medical Margins & Growth Rates
Neola Medical's revenue in the last 12 month grew by 8%.
Neola Medical's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.3M for the same period.
Neola Medical Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 8% | XXX | 7% | XXX | XXX | XXX |
| EBITDA Margin | (115%) | XXX | (114%) | XXX | XXX | XXX |
| EBITDA Growth | 32% | XXX | 4% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.3M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 223% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Neola Medical Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Neola Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| Qlife Holding | XXX | XXX | XXX | XXX | XXX | XXX |
| ScandiDos | XXX | XXX | XXX | XXX | XXX | XXX |
| Spineway | XXX | XXX | XXX | XXX | XXX | XXX |
| Bio-Gate | XXX | XXX | XXX | XXX | XXX | XXX |
| Inventionmed | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Neola Medical M&A Activity
Neola Medical acquired XXX companies to date.
Last acquisition by Neola Medical was on XXXXXXXX, XXXXX. Neola Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Neola Medical
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialNeola Medical Investment Activity
Neola Medical invested in XXX companies to date.
Neola Medical made its latest investment on XXXXXXXX, XXXXX. Neola Medical invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Neola Medical
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Neola Medical
| When was Neola Medical founded? | Neola Medical was founded in 2016. |
| Where is Neola Medical headquartered? | Neola Medical is headquartered in Sweden. |
| How many employees does Neola Medical have? | As of today, Neola Medical has over 7 employees. |
| Is Neola Medical publicly listed? | Yes, Neola Medical is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of Neola Medical? | Neola Medical trades under NEOLA ticker. |
| When did Neola Medical go public? | Neola Medical went public in 2020. |
| Who are competitors of Neola Medical? | Neola Medical main competitors are Qlife Holding, ScandiDos, Spineway, Bio-Gate. |
| What is the current market cap of Neola Medical? | Neola Medical's current market cap is $6M. |
| What is the current revenue of Neola Medical? | Neola Medical's last 12 months revenue is $953K. |
| What is the current revenue growth of Neola Medical? | Neola Medical revenue growth (NTM/LTM) is 8%. |
| What is the current EV/Revenue multiple of Neola Medical? | Current revenue multiple of Neola Medical is 4.6x. |
| Is Neola Medical profitable? | No, Neola Medical is not profitable. |
| What is the current EBITDA of Neola Medical? | Neola Medical has negative EBITDA and is not profitable. |
| What is Neola Medical's EBITDA margin? | Neola Medical's last 12 months EBITDA margin is (115%). |
| What is the current EV/EBITDA multiple of Neola Medical? | Current EBITDA multiple of Neola Medical is (4.0x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.